Back to results
US 2022/0017489 A1Published application
Solid dispersions for treatment of cancer
AssigneeCelgene Corporation
InventorsEric A. Fromme, Kevin J. Klopfer
Life of this patent
Estimating the term…
Abstract
Provided herein are amorphous solid dispersions comprising Compound 1 and a polymer. Pharmaceutical compositions comprising the solid dispersions and methods for treating, preventing and managing cancer are also disclosed.
Claims31
A solid dispersion comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, prodrug, or clathrate thereof (Compound 1) dispersed in a solid matrix that comprises a polymer.
25-37. (canceled)
Dependencies are inferred from the claim text.